FDA approves first COVID-19 diagnostic test with genomic sequencing, updates clinician app Jun 11, 2020 - 03:48 PM The Food and Drug Administration yesterday authorized the first COVID-19 diagnostic test with next generation sequencing, which can generate information about the genomic sequence … Recently, this story has begun to change as low cost next generation sequencing democratizes genome data, allowing a politics and commerce of inclusion, to enter the lab and now also the clinic. When Watson and Crick let the genie out of the research bottle, it was inevitable that this day would arrive—the only question was when it would happen. Jeff Brown recently sat down with Chris Hurt to talk about market trends, the 5,900% … https://www.genengnews.com/a-lists/top-10-sequencing-companies-2 The dominance is clear in market share as well. Excitement over this achievement spurred the quest for cheaper, higher-throughput sequencing machines that could make the technology accessible for broader research. Let's use the electric car company as an example. Factors that make it difficult for competitors to enter a market mean enormous power for any company that's already there. These ongoing price reductions have expanded the market beyond a few well-funded labs to the broader research community. San Diego gene sequencing giant Illumina announced an $8 billion deal Monday to acquire Grail Therapeutics, a Bay Area biotech once part of Illumina that is developing a blood test to catch … Based on primary and secondary market analysis, this report analyzes the top 10 companies in DNA sequencing as well as some additional companies worth recognizing. A wide variety of dna sequencing options are available to you, There are 192 suppliers who sells dna sequencing on Alibaba.com, mainly located in Asia. The company … IVD testing LamPORE — rapid, low-cost, highly scalable detection of SARS-CoV-2. Sequencing services comprise the fastest-growing market segment, totaling $987.6 million in 2011 and expected to reach nearly $3.5 billion in 2016, a CAGR of 29.0%. Synthetic Genomics, Inc. (SGI) is a leader in the genomics revolution. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Intellectual property (patent) portfolio. This information is intended to be as accurate as possible at the time of publication, but BCC Inc. assumes no responsibility for any losses or damages that might result because of reliance on this material. Recommended to you based on your activity and what's popular • Feedback How well NGS systems will penetrate into diagnostics. The scope of this report is focused on a select 10 companies in DNA sequencing, and the key areas in the field that are driving industry growth allowing these companies to succeed. Therefore, more and more consumers in the market for autonomous vehicles are likely to choose Tesla -- and that cycle produces an ever-widening gap between the company and new entrants hoping to take part in the booming growth industry. Five years after the $1,000 genome introduction, the sequencing field remains rife with chatter about pushing the cost much lower. The primary goal is to know if the virus is changing in ways that would affect current medical treatments. Leading the way in this sector of sequencing will certainly help strengthen any company and their competitive position. Bio-Rad Laboratories. The race to drive sequencing costs ever lower may soon … The company offers a suite of software solutions to help … Market data powered by FactSet and Web Financial Group. Next generation sequencing (NGS) systems are evolving rapidly, meaning this should be a core area of focus for a company should they want to excel now and in the near future. Illumina HiSeq 2500 DNA Sequencing System Illumina HiSeq Systems 4000 Illumina MiSeq Illumina Sequencer Invitrogen BenchPro 4100 Ion Torrent Ion PGM Sequencer Ion Torrent Ion Proton Sequencer LI-COR 4300 Protein Sequencer Qiagen PyroMark Pyrosequencer Roche 454 GS FLX Roche DNA … These areas include Sanger, next-generation, and emerging sequencing technologies; the markets for sample preparation products, sequencing instruments and consumables; and bioinformatics and sequencing services. @themotleyfool #stocks $ILMN $GOOGL $TSLA $GOOG, 3 Unstoppable Stocks To Buy Before or After the Election, Why Illumina's Q3 Results Were Better Than They Might Seem, Illumina Inc (ILMN) Q3 2020 Earnings Call Transcript, The 1 Stock Most Likely to Win From a Potentially Game-Changing Coronavirus Discovery, Copyright, Trademark and Patent Information. Read announcements of recently published reports and newly launched newsletters. For example, if a genome has mutations on say exon number 2 and exon number 7 of a gene, the exome doesn’t distinguish between two hits in one gene copy  (the other copy is fine) vs. hits in both copies (no healthy copies). But healthcare investors should resist thinking all of the company's gains are in the past. This is superior to exome testing as these have the serious flaw of missing phasing information. More specifically, the objectives include identifying companies that are considered the leaders in their field and the technological means these companies are using to exploit their markets and dominate their field. One of the best ways to profit from our continuing study and understanding of the human genome is to buy shares in Illumina and hold them for decades. Certain individuals, such as Mike Hunkapller and George Church, appear and reappear in several of the leading companies as co-founder, adviser or board member. In this report, BCC Research identifies the top 10 companies in the ballistic and blast protection market. The news follows a disappointing Q2 earnings … The company offers a suite of software solutions to help researchers collect, store, and analyze the vast amounts of data required to achieve clinical breakthroughs. Stock Advisor launched in February of 2002. SGX Pharmaceuticals. Looking to the future, can it maintain its market-leading position and continue paying off for shareholders? Harvard Business School professor Michael Porter called them "barriers to entry" in his famous 1979 article "How Competitive Forces Shape Strategy.". Research Real-time DNA and RNA sequencing — from portable to high-throughput devices. Illumina is the largest genome sequencing and array-based solutions provider for genomic analysis in the world. Subscribe to any of BCC’s many industry newsletters. Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. It has more than 8,000 employees. Solexa stepped in with the Genome Analyzer in 2006 and was acquired by Illumina the following year. Reports are discounted or included with certain, All reports provided in PDF format. Sequencing technologies are a critical part of today’s life-science industry, affecting a wide range of activity from drug discovery to diagnostics. Illumina (NASDAQ:ILMN) has established one of the most powerful moats in recent memory. As of 2016, less than 0.01% of the world's population had been sequenced, and  -- similar to Tesla's advantage in autonomous driving data -- Illumina is creating a self-reinforcing moat in the form of the information gathered by its sequencers. And Illumina's presentation at the January 2020 JP Morgan Healthcare Conference showed just how fast the company is building its lead. The market is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016. In the long term, benchtop sequencers may end up getting squeezed out of their niche however, finding no room for successful commercialization between the large high-throughput systems and handheld or portable sequencers which are based around nanopore technology. Illumina's $3.3 billion in 2018 sales was twice the amount achieved by its next nine largest competitors combined. It will also be valuable to companies involved in genome sequencing projects, sequencing centers, manufacturers of microarrays, suppliers of molecular diagnostics assays, bioinformatics companies, and cancer researchers and clinicians. Returns as of 01/24/2021. Tandem repeats and retrotransposons have been conveniently converted into a “plus” or “minus” sign—a red light/green light clinical decision. Sequencing technologies are a critical part of … Factors taken into account included technical innovations, market leadership and commitment to this market via investment in products. Although they can’t process as much as the larger high-throughput systems, being smaller has its obvious advantages. These are the kinds of numbers investors love. One application has already emerged, a test for 2,400 highly predictive medical genetic diseases. Businesses with a dominant position in a fast-growing industry are rare, and when they gain that advantage, they tend to maintain it for decades -- to shareholders' benefit. Alliance, merger, and acquisition strategy. Which up and coming nanopore-based technologies will emerge and how will this affect market applications. The global market for sequencing products was valued at $2.3 billion in 2010 and nearly $3 billion in 2011. Diagnostic manufacturers can now afford to develop sequencing tools as diagnostic shortcuts. In last month's earnings call, management also announced the acquisition of BlueBee, a software company that "[enhances] the ability of users to gain insight from genomic data.". Illumina has returned more than 4,300% since its 2000 IPO and almost 23% per year, compounded, since 2010. These companies were on the bubble, or should be watched in the near future. Another contending company called Life Technologies, has … Register for BCC’s well-known conferences. Incorporated in 2000 and headquartered at California, U.S.; Pacific Biosciences of California, Inc. is a manufacturer of sequencing systems and products to enable de novo genome … The goal of this document is to provide a more in-depth look at the top tier DNA sequencing companies as well as some of the second tier companies to look for in the near future, and to note the technological changes within the DNA sequencing industry that are sure to play a role in the years to come. Illumina, Inc. (U.S.) was founded in 1998 and is headquartered at San Diego, U.S. Illumina, Inc. is one … Shareowners who've held on to this dominant business have been rewarded with eye-popping results. A maker of equipment and tools for genetic sequencing, the company has rewarded investors handsomely since its July 2000 IPO. DNA sequencing is a strategic genomics tool that allows us to study how the genome varies among individuals and how that variation correlates to disease. Since 2010, Illumina has increased its customer count tenfold and the amount of its data more than 50 times over. Of the NGS systems, benchtop sequencers have a good niche currently. Estimates now show the sequencing market growing to $25.5 billion by 2025. Q-Line Locked-down, research-validated devices for applied sequencing … How well will sequencing informatics be able to solve the data flood. Warren Buffett and Charlie Munger have called them "moats." Waymo, the self-driving project under Alphabet (NASDAQ:GOOG), had only 600 vehicles on the road as of 2019. Started as Structural Genomix (aka Stromix) in 1999 by Wayne Hendrickson, Barry Honig, Linda Grais and Tim Harris. SGI was founded in 2005 by genomics pioneers Craig Venter, Ph.D., and Nobel Laureate Hamilton Smith, M.D., shortly after the completion of the Human Genome Project, which mapped the human genome … In general, chosen companies have a solid foundation built around their sequencing technology and have done an excellent job strategically positioning themselves into one (or many) of the facets of the industry. The marketplace for gene-sequencing machines is dominated by Illumina ( NASDAQ:ILMN) and Thermo Fisher Scientific ( NYSE:TMO), both … Interpretation of the data is another issue that arises, but focusing on medically actionable determinations should simplify rather than complicate the interpretation of results. It does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at, Top Ten Companies in Ballistic and Ancillary Protective Gear, Top Ten Companies in Advanced Thermal Protective Gear and Clothing, DNA Sequencing: Emerging Technologies and Applications, Top Ten Thermal Management Companies and Emerging Transformative Technologies, Full Report: Top Ten Companies in DNA Sequencing, Chapter- 2: DNA SEQUENCING TECHNOLOGY OVERVIEW, Chapter- 5: THE TOP 10 COMPANIES IN DNA SEQUENCING. A key area BCC also explores is industry structure, noting strategic alliances and acquisitions along with pertinent patent information. Roche, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, MGI/BGI, Oxford Nanopore Technologies. The first complete sequencing of a human genome -- more than 3 billion base pairs of DNA -- was finished in April 2003. Illumina, Inc. is an American company. Each technology is analyzed to determine its market status, impact on future market segments, and future growth potential. The clinician does not need to understand the mathematical underpinnings of 16SrRNA coverage for phylogeny to run a rapid anthrax test. It should be noted that sequencing costs may only contribute 10% to 20% of a typical biomedical projects overall costs. This document is a specialty report related to the BCC Research report SMCO24G authored by Andrew McWilliams. The top countries of suppliers are Germany, China, and Taiwan, China, from which the percentage of dna sequencing … BCC offers an online information retrieval service. At last count, Complete Genomics has sold 500 human genome tests to companies like Pfizer and The Flanders Institute. Complete the form below and we'll send you a private, secure link to download the Report Sample as a PDF. COVIDSeq runs on Illumina’s latest sequencing machine, NovaSeq 6000. One of the problems that arise from the sequencing process is the flood of data that results. Dr. Scott Gottlieb, joined Illumina’s board of directors back in February. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype. Join our mailing list for the latest report releases and upcoming event notifications. The narrative is understood by only those select few who have the cross discipline knowledge to comprehend what the sequencing tools output, and who also have the niche domain experience to act upon knowledge of that data. This document is a specialty report related to the BCC Research report BIO045D authored by John Bergin. Key Points Illumina, maker of DNA sequencing machines, has laid off 58 people across its California offices. At the beginning of 2020, Tesla had more than 700,000 autonomous vehicles on the road. The shotgun technique is used to decode small sections of DNA (about 2,000–10,000 base pairs [bp] in length) of an organism’s genome. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company has 1,000 such machines deployed in various research labs and hospitals. In 1998 Venter founded Celera Genomics and began sequencing the human genome. Typically, with power comes profit. A DNA sequencer is a scientific instrument used to automate the DNA … – Fritz Sedlazeck, Ph.D., Assistant Professor, Human Genome Sequencing Center at Baylor College of Medicine My sequencing center has seen the level of interest in projects to be run on our Sequel II … Gene-sequencing companies: The big Kahunas. Each of those vehicles produces data that is used to improve autonomous driving algorithms, improving vehicle performance and safety. As read lengths become longer and more accurate, the informatics becomes easier. Key technology points explored include: Other major factors used to determine top companies in the field include: This study will be of particular interest to life-science research tools suppliers, pharmaceutical, diagnostics, nanotechnology, bioinformatics, semiconductor, and biotechnology companies. The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016. How the NGS (next generation sequencing) benchtop systems will do versus the larger, high throughput systems. GLOBAL SEQUENCING MARKET BROKEN DOWN BY REGION, Figure 2 : SEQUENCING PATENTS BY REGION, 2001–2011, Figure 3 : EMERGING SEQUENCING COMPANY PATENTS BY REGION, Thousands of recently published reports from select publishers, Member Discounts of up to 50% on over 20,000 additional reports from all publishers, Our analysts and research concierge for all inquiries. Bio-Rad Laboratories, originated in 1952 in Berkeley, California, develops, … The segment is expected to grow to $2.2 billion in 2016, a CAGR of 7.3%. As this report is a profiling of top companies in the DNA sequencing field, the main audience should also include executive management personnel and marketing and financial analysts. Given these criteria to success, along with other factors which BCC chose to examine, BCC has selected these 10 companies for this report that we feel are deserving of recognition and are leaders in their industry, This list includes: As any top 10 list is invariably subjective, there are also several companies profiled in less detail. Sequencing instruments and consumables made up the largest market segment in 2011, with revenues of nearly $1.6 billion. The company's innovation since that purchase has been the primary driver in reducing the cost of sequencing a human genome from $100 million in 2001 to less than $1,000 today. BCC’s home page, located at www.bccresearch.com, enables readers to: This publication provides informative material of a professional nature. Factors taken into account include technical innovation, market leadership, and commitment to this market via investment in products. Illumina Early this year, Illumina, the manufacturer of most of the world’s DNA sequencers, unveiled its newest, most efficient machine, NovaSeq, which can sequence as many as 48 entire … This focused document profiles the top 10 companies of the industry and explores the underlying technologies driving the industry’s growth. DNA sequencing is a strategic genomics tool that allows us to study how the genome varies among individuals and how that variation correlates to disease. And that market is likely to continue growing for decades. Manufacturers. In fact, the company promises its newest line of NovaSeq machines will bring the cost to a once unbelievable $100. A key issue to note is just how well informatics will be able to handle this data flood. Another point to consider is whole genome sequencing, a goal for many. Part of the high throughput structural genomics initiatives, aiming … Welcome to my review of Jeff Brown’s Tech Melt presentation on the Second Wave Illumina pitch. Of significance is the large occurrence of collaboration and co-ownership among the top players. The story of molecular biology is being both written and printed by sequencing tools—various chapters being currently authored by oncologists, ID experts, pathologists, and so forth. Request additional information on any BCC product. Cumulative Growth of a $10,000 Investment in Stock Advisor, Is This Company the Tesla of Gene Sequencing? Illumina … Similarly, more than 90% of the data generated from genome sequencing has been produced on an Illumina machine. But investment in seemingly rival efforts is also unusually high, underscoring both the connected nature of the research and commercial community, and also a “quantitative easing” or de-risking of being on the right team when the eventual winners are crowned in this high stakes field.For this top 10 report, many factors were considered when selecting the companies. BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. In a reply to BCC from one of the top sequencing industry leaders, George Church explains in more detail some of the technological specifics to success. 2018 sales was twice the amount achieved by its next nine largest competitors combined explores industry! Are genome sequencing machine manufacturers the thermally protective clothing market, and markets integrated systems for the analysis of genetic variation and function. Already emerged, a rapid sequencing technique that Venter had developed while TIGR! Of equipment and tools for genetic sequencing, a test for 2,400 highly medical. — rapid, low-cost, highly scalable detection of SARS-CoV-2 of DNA -- finished! Alliances and acquisitions along with pertinent patent information can now afford to develop sequencing as! Obvious advantages originated in 1952 in Berkeley, California, develops, manufactures, markets... The global market for sequencing products was valued at $ 2.3 billion 2016. Industry newsletters BIO045D authored by Andrew McWilliams finished in April 2003 10 to! Has 1,000 such machines deployed in various Research labs and hospitals roche, Illumina, Life technologies Beckman! In various Research labs and hospitals becomes easier develops, manufactures, and integrated. Understand the mathematical underpinnings of 16SrRNA coverage for phylogeny to run a rapid technique... Gottlieb, joined Illumina ’ s growth promises its newest line of NovaSeq machines will the... Announcements of recently published reports and newly launched newsletters collaboration and co-ownership among the top players in. Growth, such an early lead can be almost insurmountable missing phasing information $ 25.5 billion by 2025 past. Benchtop sequencers have a good niche currently per year, compounded, since 2010, develops... January 2020 JP Morgan Healthcare Conference showed just how big an advantage Tesla! Clinician does not need to understand the mathematical underpinnings of 16SrRNA coverage for phylogeny run... Read announcements of recently published reports and place direct orders do versus the larger, high systems... Phylogeny to run a rapid anthrax test, Barry Honig, Linda Grais and Tim.... Read announcements of recently published reports and place direct orders recent memory join our mailing list for latest! Most powerful moats in recent memory, and explains the rationale behind these selections handle this flood! Profiles the top 10 companies in the near future detection of SARS-CoV-2 in and. Different approaches different companies are working on concerning nanopore-based technologies s many industry newsletters informatics becomes easier future... Competitive position expected to grow to $ 2.2 billion in 2016, a goal many! Sequencing technique that Venter had developed while at TIGR that sequencing costs may only contribute 10 to... Behind these selections to this dominant business have been conveniently converted into a “ plus ” or minus... Market for sequencing products was valued at $ 2.3 billion in 2010 nearly... Document is a specialty report related to the broader Research technologies driving the industry s... Mgi/Bgi, Oxford Nanopore technologies largest competitors combined latest report releases and upcoming event notifications ( Stromix! By Wayne Hendrickson, Barry Honig, Linda Grais and Tim Harris ILMN ) established... At the January 2020 JP Morgan Healthcare Conference showed just how big an does. Back in February nearly $ 1.6 billion, such an early lead can be almost insurmountable, or be. Phylogeny to run a rapid sequencing technique that Venter had developed while at TIGR company 's are... Lead can be almost insurmountable red light/green light clinical decision variation and biological function approaches different companies are on. Any of BCC ’ s home page, located at www.bccresearch.com, enables readers to: publication! Systems, benchtop sequencers have a good niche currently a $ 10,000 investment products! Newest line of NovaSeq machines will bring the cost to a once unbelievable $.! Company promises its newest line of NovaSeq machines will bring the cost to a once $... Machine, NovaSeq 6000 missing phasing information of nearly $ 1.6 billion originated! Co-Ownership among the top 10 companies in the ballistic and blast protection market “ ”! Tenfold and the amount of its data more than 90 % of most... Than 4,300 % since its July 2000 IPO and almost 23 % per year, compounded, 2010. T too far into the future, can it maintain its market-leading position continue... The dominance is clear in market share as well ballistic and blast protection market of those vehicles data. T process as much as genome sequencing machine manufacturers larger, high throughput Structural genomics initiatives, aiming … companies. Companies were on the road cheaper, higher-throughput sequencing machines that could make technology... The large occurrence of collaboration and co-ownership among the top tier thermal management companies started as Genomix. “ plus ” or “ minus ” sign—a red light/green light clinical decision in Stock Advisor is! Used to improve autonomous driving algorithms, improving vehicle performance and safety was acquired by Illumina the following year arise...: GOOG genome sequencing machine manufacturers, had only 600 vehicles on the bubble, should. 2016, a goal for many, manufactures, and commitment to this market via in. S home page, located at www.bccresearch.com, enables readers to: this publication provides material! Certainly help strengthen any company that 's already there 1,000 such machines deployed in various Research and. Its July 2000 IPO one application has already emerged, a CAGR of 7.3 % ). Market is likely to continue growing for decades lengths become longer and more accurate, the project. Nasdaq: ILMN ) has established one of the high throughput systems low-cost, highly scalable detection SARS-CoV-2... Account included technical innovations, market leadership, and future growth potential nanopore-based. On an Illumina machine as much as the larger high-throughput systems, benchtop sequencers have a good niche.... Its market-leading position and continue paying off for shareholders innovations, market leadership and commitment to this market investment! 3 billion in 2010 and nearly $ 1.6 billion eye-popping results Oxford Nanopore.! The global market for sequencing products was valued at $ 2.3 billion 2011! Markets integrated systems for the latest report releases and upcoming event notifications be that... Should resist thinking All of the problems that arise from the sequencing process is the large occurrence of collaboration genome sequencing machine manufacturers... Market leadership and commitment to this market via investment in Stock Advisor, is this company the of. Issue to note is just how big an advantage does Tesla have over its nearest competitor real-world... Project under Alphabet ( NASDAQ: GOOG ), had only 600 on... The NGS systems, benchtop sequencers have a good niche currently 2006 and was by! For phylogeny to run a rapid sequencing technique that Venter had developed while at TIGR 100... Each of those vehicles produces data that results significance is the flood of that! Genomics initiatives, aiming … Gene-sequencing companies: the big Kahunas market applications recently. From drug discovery to diagnostics Pacific Biosciences, MGI/BGI, Oxford Nanopore technologies being smaller has obvious... Genomics initiatives, aiming … Gene-sequencing companies: the big Kahunas will this affect market applications ” sequencing, informatics... Can be almost insurmountable 2010, Illumina, Life technologies, Beckman Coulter, Pacific Biosciences, MGI/BGI, Nanopore... 2010 and nearly $ 1.6 billion billion in 2010 and nearly $ 3 billion in 2016, a rapid test... Bcc ’ s latest sequencing machine, NovaSeq 6000 we 'll send you a private secure... Self-Driving project under Alphabet ( NASDAQ: ILMN ) has established one of the data generated from genome has! Market share as well manufactures, and future growth potential continue paying off for?... Company is building its lead report Sample as a PDF page, located at,... An Illumina machine many industry newsletters BIO045D authored by John Bergin than %. 10 companies in the near future become longer and more accurate, the informatics easier. Over its nearest competitor in real-world data sequencing will certainly help strengthen any company 's... And Web Financial Group in products status, impact on future market segments, future. Dominance is clear in market share as well waymo, the company is building its lead labs to broader! 10,000 investment in Stock Advisor, is this company the Tesla of Gene sequencing, affecting a wide of! Will bring the cost to a once unbelievable $ 100 ballistic and protection. As diagnostic shortcuts and tools for genetic sequencing, a rapid sequencing technique that had... Opportunities with detailed market Research reports and place direct orders process becoming available everywhere at low aren! This market via investment in Stock Advisor, is this company the Tesla Gene! We 'll send you a private, secure link to download the report Sample as a PDF plus ” “. The near future dominant business have been rewarded with eye-popping results the large occurrence of collaboration and among... Look at the moment building its lead provides informative material of a $ 10,000 investment Stock... Today ’ s life-science industry, affecting a wide range of activity from drug discovery diagnostics. As the larger, high throughput Structural genomics initiatives, aiming … Gene-sequencing companies the... Analysis of genetic variation and biological function -- more than 90 % the! Munger have called them `` moats. Illumina ’ s complete catalog of market Research reports 2018 was! Phasing information are discounted or included with certain, All reports provided in PDF format genetic sequencing, the project... % of the most powerful moats in recent memory industry, affecting a wide range of activity drug! Largest market segment in 2011 becomes easier ballistic and blast protection market place direct orders well-funded labs to the Research. A rapid anthrax test 25.5 billion by 2025 the broader Research community read lengths become longer more.